JP2000509243A5 - - Google Patents

Download PDF

Info

Publication number
JP2000509243A5
JP2000509243A5 JP1997516925A JP51692597A JP2000509243A5 JP 2000509243 A5 JP2000509243 A5 JP 2000509243A5 JP 1997516925 A JP1997516925 A JP 1997516925A JP 51692597 A JP51692597 A JP 51692597A JP 2000509243 A5 JP2000509243 A5 JP 2000509243A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997516925A
Other languages
English (en)
Other versions
JP2000509243A (ja
JP3905127B2 (ja
Filing date
Publication date
Priority claimed from AUPN6313A external-priority patent/AUPN631395A0/en
Application filed filed Critical
Publication of JP2000509243A publication Critical patent/JP2000509243A/ja
Publication of JP2000509243A5 publication Critical patent/JP2000509243A5/ja
Application granted granted Critical
Publication of JP3905127B2 publication Critical patent/JP3905127B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

Figure 2000509243
Figure 2000509243
Figure 2000509243
Figure 2000509243
Figure 2000509243
JP51692597A 1995-11-02 1996-11-01 パスツレラ・ヘモリチカ白血球毒素に対する免疫 Expired - Lifetime JP3905127B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU6313 1994-07-15
AUPN6313A AUPN631395A0 (en) 1995-11-02 1995-11-02 Vaccine and biological vector(II)
PCT/AU1996/000685 WO1997016531A1 (en) 1995-11-02 1996-11-01 Immunity against pasteurella haemolytica leukotoxin

Publications (3)

Publication Number Publication Date
JP2000509243A JP2000509243A (ja) 2000-07-25
JP2000509243A5 true JP2000509243A5 (ja) 2004-09-16
JP3905127B2 JP3905127B2 (ja) 2007-04-18

Family

ID=3790638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51692597A Expired - Lifetime JP3905127B2 (ja) 1995-11-02 1996-11-01 パスツレラ・ヘモリチカ白血球毒素に対する免疫

Country Status (11)

Country Link
US (1) US6610307B1 (ja)
EP (1) EP0862615B1 (ja)
JP (1) JP3905127B2 (ja)
AU (1) AUPN631395A0 (ja)
BR (2) BR9611278A (ja)
CA (1) CA2236700C (ja)
DE (1) DE69631543T2 (ja)
ES (1) ES2211982T3 (ja)
MX (1) MX9803370A (ja)
NZ (1) NZ320025A (ja)
WO (1) WO1997016531A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840556A (en) 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
US6770275B1 (en) * 1996-05-31 2004-08-03 Akzo Nobel N.V. Live attenuated RTC-producing bacteria of the family
AU743654B2 (en) * 1997-09-25 2002-01-31 Biotechnology Research And Development Corporation LKTA deletion mutant of P. haemolytica
US6936262B2 (en) 1997-09-25 2005-08-30 Biotechnology Research And Development Corporation LktA deletion mutant of P. haemolytica
US8053406B2 (en) 2005-11-25 2011-11-08 University Of Medicine And Dentistry Of New Jersey Compositions for the treatment of cancer, and methods for testing and using the same
US8926990B2 (en) 2009-10-13 2015-01-06 Rutgers, The State University Of New Jersey Treatment and diagnosis of inflammatory disorders and HIV
WO2007062150A2 (en) * 2005-11-25 2007-05-31 University Of Medicine And Dentistry Of New Jersey Leukotoxin compositions and therapeutic methods
US10149889B2 (en) 2005-11-25 2018-12-11 Rutgers, The State University Of New Jersey Compositions for the treatment of cancer, and methods for testing and using the same
EP3384927B1 (en) 2012-11-08 2022-07-06 Boehringer Ingelheim Animal Health USA Inc. Attenuated manheimia haemolytica vaccines and methods of making and use
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
NL2018155B1 (en) 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963487A (en) * 1985-01-03 1990-10-16 Massachusetts Institute Of Technology Method for deletion of a gene from a bacteria
US5165924A (en) 1986-01-22 1992-11-24 University Of Guelph Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle
US5885589A (en) * 1988-04-12 1999-03-23 Intervet International B.V. Pasteurella vaccine
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines
US5641653A (en) * 1989-10-31 1997-06-24 The Texas A&M University System DNA encoding Actinobacillus pleuropneumoniae hemolysin
CA2045950C (en) * 1991-06-28 2004-05-11 Elbarte M. Kamp Recombinant vaccine for prevention and/or treatment of pleuropneumonia infections
US5422110A (en) * 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
AUPN631495A0 (en) * 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(I)
AU6969798A (en) * 1997-04-15 1998-11-11 Baylor College Of Medicine (pasteurella haemolytica) vaccine

Similar Documents

Publication Publication Date Title
JP2000500445A5 (ja)
JP2000500228A5 (ja)
JP2000500440A5 (ja)
JP2000500327A5 (ja)
JP2000500145A5 (ja)
JP2000500155A5 (ja)
JP2000500406A5 (ja)
JP2000500361A5 (ja)
JP2000500115A5 (ja)
JP2000508088A5 (ja)
JP2000500322A5 (ja)
JP2000500258A5 (ja)
JP2000500192A5 (ja)
JP2000500342A5 (ja)
JP2000500112A5 (ja)
JP2000500397A5 (ja)
JP2000500226A5 (ja)
JP2000500051A5 (ja)
JP2000500407A5 (ja)
JP2000500166A5 (ja)
JP2000500257A5 (ja)
JP2000500125A5 (ja)
JP2000500090A5 (ja)
JP2000500346A5 (ja)
JP2000500429A5 (ja)